For example, while inhibition of BRAF or MEK in A375 melanoma cell line resulted in activation of the YAP/TAZ pathway, the effect of BRAF/MEK inhibition in the SK-MEL-5 cell line resulted in inhibition of the YAP/TAZ pathway (Supplementary Fig. 3E–H). Here, MAP2K7 is linked to melanoma.